Oxidative stress impairs learning and memory in apoE knockout mice

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 2, 2010, Pages 181-186

  Evola, Marianne ^a   Hall, Allyson ^a   Wall, Trevor ^a   Young, Alice ^a   Grammas, Paula ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

ApoE knockout; Apolipoprotein E; Cognition; Cytokines; Homocysteine; Inflammation; Oxidative stress; Radial arm maze

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HOMOCYSTEINE; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD VESSEL; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPATIAL MEMORY; VASCULARIZATION; ANIMAL; BLOOD; BRAIN; C57BL MOUSE; COGNITION; DEFICIENCY; DIET; DRUG EFFECTS; GENETICS; MEMORY; METABOLISM; PHYSIOLOGY;

ANIMALS; APOLIPOPROTEINS E; BRAIN; CHOLESTEROL; COGNITION; DIET; HOMOCYSTEINE; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS;

MUS;

EID: 77953728876     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.05.003     Document Type: Article

References (53)

1. Anstey K.J., Lipnicki D.M., Low L.F. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 2008, 16:343-354.
2. Auer J., Berent R., Eber B. Homocysteine and dementia. N Engl J Med 2002, 346:476-483.
3. Baddeley A.D., Hitch G. The recency effect: implicit learning with explicit retrieval?. Mem Cognit 1993, 21:146-155.
4. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009, 118:103-113.
5. Borroni B., Agosti C., Panzali A.F., Di Luca M., Padovani A. Homocysteine, vitamin B6, and vascular disease in patients with AD. Neurology 2002, 59:1475. author reply 1475-6.
6. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985, 76:1501-1513.
7. Champagne D., Dupuy J.B., Rochford J., Poirier J. Apolipoprotein E knockout mice display procedural deficits in the Morris water maze: analysis of learning strategies in three versions of the task. Neuroscience 2002, 114:641-654.
8. Conway A.R., Kane M.J., Bunting M.F., Hambrick D.Z., Wilhelm O., Engle R.W. Working memory span tasks: a methodological review and user's guide. Psychon Bull Rev 2005, 12:769-786.
9. Dorheim M.A., Tracey W.R., Pollock J.S., Grammas P. Nitric oxide is elevated in Alzheimer's brain microvessels. Biochem Biophys Res Commun 1994, 205:659-665.
10. Elshourbagy N.A., Liao W.S., Mahley R.W., Taylor J.M. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A 1985, 82:203-207.
11. Gallistel C.R., Fairhurst S., Balsam P. The learning curve: implications of a quantitative analysis. Proc Natl Acad Sci U S A 2004, 101:13124-13131.
12. Grammas P., Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging 2001, 22:837-842.
13. Grammas P., Ghatreh-Samany P., Thirmangalakudi L. Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implications for disease pathogenesis. J Alz Dis 2006, 9:51-58.
14. Grootendorst J., Bour A., Vogel E., Kelche C., Sullivan P.M., Dodart J.C., et al. Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav Brain Res 2005, 159:1-14.
15. Hafezi-Moghadam A., Thomas K.L., Wagner D.D. ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage. Am J Physiol Cell Physiol 2007, 292:C1256-C1262.
16. Herrmann W., Knapp J.P. Hyperhomocysteinemia: a new risk factor for degenerative diseases. Clin Lab 2002, 48:471-481.
17. Herrmann W., Herrmann M., Obeid R. Hyperhomocysteinemia: a critical review of old and new aspects. Curr Drug Metab 2007, 8:17-31.
18. Hirsch-Reinshagen V., Burgess B.L., Wellington C.L. Why lipids are important for Alzheimer disease?. Mol Cell Biochem 2009, 326:121-129.
19. Hodges H. Maze procedures: the radial-arm and water maze compared. Brain Res Cogn Brain Res 1996, 3:167-181.
20. Korczyn A.D. Homocysteine, stroke, and dementia. Stroke 2002, 33:2343-2344.
21. Kronenberg G., Colla M., Endres M. Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med 2009, 9:315-323.
22. Law A., Gauthier S., Quirion R. Alteration of nitric oxide synthase activity in young and aged apolipoprotein E-deficient mice. Neurobiol Aging 2003, 24:187-190.
23. Lendon C.L., Han B.H., Salimi K., Fagan A.M., Behrens M.I., Muller M.C., et al. No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo. Eur J Neurosci 2000, 12:2235-2242.
24. Mahley R.W., Rall S.C. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000, 1:507-537.
25. Makhro A.V., Mashkina A.P., Solenaya O.A., Trunova O.A., Kozina L.S., Arutyunian A.V., et al. Prenatal hyperhomocysteinemia as a model of oxidative stress of the brain. Bull Exp Biol Med 2008, 146:33-35.
26. McIlroy S.P., Dynan K.B., Lawson J.T., Patterson C.C., Passmore A.P. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002, 33:2351-2356.
27. Meir K.S., Leitersdorf E. Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 2004, 24:1006-1014.
28. Mihalick S.M., Ortiz D., Kumar R., Rogers E., Shea T.B. Folate and vitamin E deficiency impair cognitive performance in mice subjected to oxidative stress: differential impact on normal mice and mice lacking apolipoprotein E. Neuromolecular Med 2003, 4:197-202.
29. Miller J.W., Green R., Mungas D.M., Reed B.R., Jagust W.J. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 2002, 58:1471-1475.
30. Mizrahi E.H., Jacobsen D.W., Friedland R.P. Plasma homocysteine: a new risk factor for Alzheimer's disease?. Isr Med Assoc J 2002, 4:187-190.
31. Morris M.S. Folate, homocysteine, and neurological function. Nutr Clin Care 2002, 5:124-132.
32. Nilsson K., Gustafson L., Hultberg B. Relation between plasma homocysteine and Alzheimer's disease. Dement Geriatr Cogn Disord 2002, 14:7-12.
33. Nourhashemi F., Gillette-Guyonnet S., Andrieu S., Ghisolfi A., Ousset P.J., Grandjean H., et al. Alzheimer disease: protective factors. Am J Clin Nutr 2000, 71:643S-649S.
34. Olton D.S., Samuelson R.J. Remembrance of places passed: spatial memory in rats. J Exp Psychol Anim Behav Process 1976, 2:97-115.
35. Papatheodorou L., Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 2007, 9:1941-1958.
36. Prins N.D., Den Heijer T., Hofman A., Koudstaal P.J., Jolles J., Clarke R., et al. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002, 59:1375-1380.
37. Purnell C., Gao S., Callahan C.M., Hendrie H.C. Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature. Alzheimer Dis Assoc Disord 2009, 23:1-10.
38. Refolo L.M., Pappolla M.A., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000, 7:321-331.
39. Reitz C., Tang M.X., Miller J., Green R., Luchsinger J.A. Plasma homocysteine and risk of mild cognitive impairment. Dement Geriatr Cogn Disord 2009, 27:11-17.
40. Reutens S., Sachdev P. Homocysteine in neuropsychiatric disorders of the elderly. Int J Geriatr Psychiatry 2002, 17:859-864.
41. Rojo L., Sjöberg M.K., Hernández P., Zambrano C., Macciono R.B. Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's Disease. J Biomed Biotechnol 2006, 3:73976.
42. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999, 19:217-246.
43. Shea T.B., Rogers E. Homocysteine and dementia. N Engl J Med 2002, 346. 2007; author reply 2008.
44. Sheehan B., Fazel S. Elevated plasma total homocysteine increased the risk of dementia in the elderly. Evid Based Ment Health 2002, 5:126.
45. Siuda J., Gorzkowska A., Patalong-Ogiewa M., Krzystanek E., Czech E., Wiechula B., et al. From mild cognitive impairment to Alzheimer's disease-influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up. Neurol Neurochir Pol 2009, 43:321-329.
46. Sparks D.L., Martin T.A., Gross D.R., Hunsaker J.C. Link between heart disease, cholesterol, and Alzheimer's disease: a review. Microsc Res Tech 2000, 50:287-290.
47. Troen A.M., Shukitt-Hale B., Chao W.H., Albuquerque B., Smith D.E., Selhub J., et al. The cognitive impact of nutritional homocysteinemia in apolipoprotein-E deficient mice. J Alzheimers Dis 2006, 9:381-392.
48. van Meer P., Acevedo S., Raber J. Impairments in spatial memory retention of GFAP-apoE4 female mice. Behav Brain Res 2007, 176:372-375.
49. van Praag H., Shubert T., Zhao C., Gage F.H. Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci 2005, 25:8680-8685.
50. Vermeer S.E., van Dijk E.J., Koudstaal P.J., Oudkerk M., Hofman A., Clarke R., et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol 2002, 51:285-289.
51. Wakutani Y., Kowa H., Kusumi M., Yamagata K., Wada-Isoe K., Adachi Y., et al. Genetic analysis of vascular factors in Alzheimer's disease. Ann N Y Acad Sci 2002, 977:232-238.
52. Wolozin B., Kellman W., Ruosseau P., Celesia G.C., Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000, 57:1439-1443.
53. Zhou Y., Elkins P.D., Howell L.A., Ryan D.H., Harris R.B. Apolipoprotein-E deficiency results in an altered stress responsiveness in addition to an impaired spatial memory in young mice. Brain Res 1998, 788:151-159.